Overview

A 12-Week Study in Adult Subjects With Asthma

Status:
Completed

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

This will be a multi-center, randomized, placebo controlled parallel-group study to Replicate Efficacy of Nebulized Fluticasone Propionate (FP) in Adult Subjects with Partly Controlled and Uncontrolled Asthma. Individual participation will be approximately 16 weeks, including 12 weeks of double-blind treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Dey

Treatments:

Fluticasone
Xhance